Suchergebnisse - "Dogné, Jean-Michel"

PubPharm (176)

41

Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

enthalten in: Thrombosis research | 2017

von Sabor, L. | Raphaël, M. | Dogné, J. | +2

42

Characterization of core/shell Cu/Ag nanopowders synthesized by electrochemistry and assessment of their impact on hemolysis, platelet aggregation, and coagulation on human blood for potential wound dressing use

enthalten in: Journal of nanoparticle research | 2017

von Laloy, J. | Haguet, H. | Alpan, L. | +7

43

Characterization of core/shell Cu/Ag nanopowders synthesized by electrochemistry and assessment of their impact on hemolysis, platelet aggregation, and coagulation on human blood for potential wound dressing use

enthalten in: Journal of nanoparticle research | 2017

von Laloy, J. | Haguet, H. | Alpan, L. | +7

44

A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

enthalten in: Therapeutic advances in drug safety | 2017

von Maignen, F. | Hauben, M. | Dogné, J.

45

Perioperative management of patients on direct oral anticoagulants

enthalten in: Thrombosis journal | 2017

von Dubois, V. | Dincq, A. | Douxfils, J. | +7

46

Perioperative management of patients on direct oral anticoagulants

enthalten in: Thrombosis journal | 2017

von Dubois, V. | Dincq, A. | Douxfils, J. | +7

47

Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia : A Review

enthalten in: Molecules (Basel, Switzerland) | 2017

von Minet, V. | Dogné, J. | Mullier, F.

48

Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia

enthalten in: Journal of thrombosis and thrombolysis | 2017

von Gheldof, D. | Haguet, H. | Dogné, J. | +7

49

Impact of the Direct Oral Anticoagulants on Activated Clotting Time

enthalten in: Journal of cardiothoracic and vascular anesthesia | 2017

von Dincq, A. | Lessire, S. | Chatelain, B. | +4

50

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2017

von Haguet, H. | Douxfils, J. | Mullier, F. | +3